Sepsis is the first cause of death for infection accounting for 17% of intra-hospital mortality and reaching 26% in case of septic shock with estimated costs for over 24 billion of dollar per year. Early diagnosis and appropriate treatment can significantly reduce sepsis mortality however there is currently no gold standard in sepsis diagnosis. To date, it is recommended to use an improved program for sepsis, including sepsis screening for acutely ill, high-risk patients and standard operating procedures for treatment in hospitals.
Sepsis screening tools are designed to promote early identification of sepsis using clinical scores and biomarkers. The combination of clinical scores and biomarkers increases the diagnostic and prognostic accuracy of sepsis, improving patient clinical management. Various clinical variables and tools are used for sepsis screening, such as vital signs, signs of infection, systemic inflammatory response syndrome (SIRS) criteria, quick Sequential Organ Failure Score (q-SOFA) or Sequential Organ Failure Assessment (SOFA) criteria, National Early Warning Score (NEWS), or Modified Early Warning Score (MEWS).
The aim of this Research topic is to increase the accuracy and speed of sepsis diagnosis by combining the dosage of biomarkers with clinical scores. For this Topic we encourage the submission of Original Research, clinical trials and review articles.
Sepsis is the first cause of death for infection accounting for 17% of intra-hospital mortality and reaching 26% in case of septic shock with estimated costs for over 24 billion of dollar per year. Early diagnosis and appropriate treatment can significantly reduce sepsis mortality however there is currently no gold standard in sepsis diagnosis. To date, it is recommended to use an improved program for sepsis, including sepsis screening for acutely ill, high-risk patients and standard operating procedures for treatment in hospitals.
Sepsis screening tools are designed to promote early identification of sepsis using clinical scores and biomarkers. The combination of clinical scores and biomarkers increases the diagnostic and prognostic accuracy of sepsis, improving patient clinical management. Various clinical variables and tools are used for sepsis screening, such as vital signs, signs of infection, systemic inflammatory response syndrome (SIRS) criteria, quick Sequential Organ Failure Score (q-SOFA) or Sequential Organ Failure Assessment (SOFA) criteria, National Early Warning Score (NEWS), or Modified Early Warning Score (MEWS).
The aim of this Research topic is to increase the accuracy and speed of sepsis diagnosis by combining the dosage of biomarkers with clinical scores. For this Topic we encourage the submission of Original Research, clinical trials and review articles.
